Long-Term Changes of Magnetization Transfer–Derived Measures from Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

References

1. ↵
   Miller DH, Albert PS, Barkhof F,, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16

   CrossRefPubMedWeb of Science
2. Filippi M, Miller DH. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 1996;9:176-186
3. Filippi M, Horsfield MA, Ader HI,, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:449-506
4. ↵
   Filippi M. The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64(Suppl):S52-S58
5. ↵
   Dousset V, Grossman RI, Ramer KN,, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

   CrossRefPubMedWeb of Science
6. Filippi M, Campi A, Dousset V,, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482

   Abstract/FREE Full Text
7. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;96:511-515
8. ↵
   van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636

   PubMedWeb of Science
9. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285

   Abstract/FREE Full Text
10. ↵
    Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994;36(Suppl):S97-S99
11. ↵
    Filippi M, Rocca MA, Rizzo G,, et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 1998;50:1289-1293

    Abstract/FREE Full Text
12. Silver NC, Lai M, Symms MR, Barker GJ, McDonald WI, Miller DH. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998;51:758-764

    Abstract/FREE Full Text
13. van Waesberghe JH, van Walderveen MA, Castelijns JA,, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683

    Abstract
14. Lai HM, Davie CA, Gass A,, et al. Serial magnetization transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311

    CrossRefPubMedWeb of Science
15. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814

    CrossRefPubMedWeb of Science
16. ↵
    Gass A, Barker GJ, Kidd D,, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67

    CrossRefPubMedWeb of Science
17. ↵
    Rovaris M, Filippi M, Falautano M,, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608

    Abstract/FREE Full Text
18. van Buchem MA, Grossman RI, Armstrong C,, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617

    Abstract/FREE Full Text
19. ↵
    Poser CM, Paty DW, Scheinberg L,, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
20. ↵
    Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911

    Abstract/FREE Full Text
21. ↵
    Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452

    Abstract/FREE Full Text
22. ↵
    Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688

    Abstract/FREE Full Text
23. ↵
    Rovaris M, Filippi M, Calori G,, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266-270

    CrossRefPubMedWeb of Science
24. ↵
    Friston KJ, Ashburner J, Poline JB,, et al. Spatial realignment and normalization of images. Hum Brain Mapping 1995;3:165-189
25. ↵
    Prineas JW, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994;36(Suppl):S42-S46
26. ↵
    van Waesberghe JHTM, van Walderveen MAA, de Groot C, et al. Postmortem correlation between axonal loss, MTR, and hypointensity on T1 SE in MS. Proceedings of the International Society for Magnetic Resonance in Medicine 1998;1334:
27. ↵
    Lexa FJ, Grossman RI, Rosenquist AC. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212

    Abstract/FREE Full Text
28. Dousset V, Brochet B, Vital A,, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225-231

    Abstract/FREE Full Text
29. Kimura H, Meaney DF, McGowan JC,, et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation. J Comput Assist Tomogr 1996;20:540-546

    CrossRefPubMedWeb of Science
30. ↵
    Dousset V, Armand JP, Lacost D,, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 1997;18:895-901

    Abstract/FREE Full Text
31. ↵
    Silver NC, Barker GJ, MacManus DG,, et al. Decreased magnetization transfer ratio due to demyelination: a case of central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1996;61:208-209

    FREE Full Text
32. ↵
    Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15-20

    FREE Full Text
33. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91

    CrossRefPubMedWeb of Science
34. Trapp BD, Peterson J, Ransohoff RM, Rudik R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285

    CrossRefPubMedWeb of Science
35. ↵
    Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 1998;158:148-153

    CrossRefPubMedWeb of Science
36. Losseff NA, Wang L, Lai HM,, et al. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 1996;119:2009-2019

    Abstract/FREE Full Text